Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Sight Sciences Posts Long-Term Safety, Effectiveness Data For Glaucoma Surgical System

Sight Sciences Inc (NASDAQ: SGHT) announced 36-month post-surgery follow-up results of the OMNI Surgical System.  The data demonstrates that the OMNI Surgical…
byVandana Singh
August 16, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0
  • Sight Sciences Inc (NASDAQ: SGHT) announced 36-month post-surgery follow-up results of the OMNI Surgical System. 
  • The data demonstrates that the OMNI Surgical System delivers safe, consistent, and durable results in adult patients with open-angle glaucoma (OAG) on a standalone basis.
  • The study showed that canaloplasty followed by trabeculectomy using the OMNI Surgical System achieved a mean reduction in intraocular pressure (IOP) of at least 20% for all 26 patients (38 eyes) at 36 months follow-up. 
  • The post-operative IOP and medication use reduction at 12 months remained consistent over three years, suggesting robust, durable effectiveness of the OMNI Surgical System. 
  • A minimal number of adverse events were reported, all resolved without intervention except one eye required secondary IOP lowering intervention.
  • Price Action: SGHT shares are down 2.86% at $8.51 during the market session on the last check Tuesday.
 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

This Analyst With 84% Accuracy Rate Boosts PT On Cracker Barrel; Here Are 5 Stock Picks For Last Week From Benzinga’s Most Accurate Analysts

By Lisa Levin
December 5, 8:19 AM
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst's opinion to trust.

APA